Suchergebnisse - "Cariou, Bertrand"

PubPharm (242)

1

Long-Term Complications of Open Mason's Vertical Banded Gastroplasty at a Single Tertiary Center and Literature Review

enthalten in: The American surgeon | 2019

von Greilsamer, T. | Jacobi, D. | Krempf, M. | +5

2

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes : The PIONEER 8 Trial

enthalten in: Diabetes care | 2019

von Zinman, B. | Aroda, V. | Buse, J. | +99

3

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING STEM CELLS PROLIFERATION OR DIFFERENTIATION

enthalten in: Europäisches Patentamt | 2019

von SI TAYEB KARIM | IDRISS SALAM | CARIOU BERTRAND | +3

4

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease : analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

enthalten in: Cardiovascular diabetology | 2019

von Ray, K. | Del Prato, S. | Müller-Wieland, D. | +9

5

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

enthalten in: Cardiovascular diabetology | 2019

von Ray, K. | Del Prato, S. | Müller-Wieland, D. | +9

6

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

enthalten in: Cardiovascular diabetology | 2019

von Ray, K. | Del Prato, S. | Müller-Wieland, D. | +9

7

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

enthalten in: BMC cardiovascular disorders | 2019

von Schmidt, A. | Holmes, M. | Preiss, D. | +162

8

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

enthalten in: BMC cardiovascular disorders | 2019

von Schmidt, A. | Holmes, M. | Preiss, D. | +162

9

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING STEM CELLS PROLIFERATION OR DIFFERENTIATION

enthalten in: Europäisches Patentamt | 2019

von SI TAYEB KARIM | IDRISS SALAM | CARIOU BERTRAND | +3

10

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

enthalten in: Diabetes technology & therapeutics | 2019

von Danne, T. | Pettus, J. | Giaccari, A. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]